Dow Jones

39 127,80

0,04%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
AMEX
Lorus Therapeutics, (New) (LRP)
Lorus Therapeutics, (New) (LRP) Actualités

LRP

Lorus Therapeutics (LRP)

Lorus Therapeutics, (New)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:AMEX:LRP

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
21/10/2014	14h00	PR Newswire (US)	Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO	AMEX:LRP	Lorus Therapeutics, (New)
03/10/2014	13h00	PR Newswire (US)	Aptose Biosciences to Present at the 2014 BIO Investor Forum	AMEX:LRP	Lorus Therapeutics, (New)
01/10/2014	23h16	PR Newswire (Canada)	Aptose Biosciences Announces Reverse Stock Split	AMEX:LRP	Lorus Therapeutics, (New)
29/09/2014	14h30	PR Newswire (US)	Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...	AMEX:LRP	Lorus Therapeutics, (New)
25/09/2014	15h48	PR Newswire (US)	Aptose Biosciences to Present at Upcoming Investor Conferences	AMEX:LRP	Lorus Therapeutics, (New)
08/09/2014	13h00	PR Newswire (US)	Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer	AMEX:LRP	Lorus Therapeutics, (New)
02/09/2014	13h00	PR Newswire (US)	Lorus Therapeutics Implements Name Change to Aptose Biosciences	AMEX:LRP	Lorus Therapeutics, (New)
19/08/2014	22h00	PR Newswire (US)	Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders	AMEX:LRP	Lorus Therapeutics, (New)
07/08/2014	13h00	PR Newswire (US)	Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference	AMEX:LRP	Lorus Therapeutics, (New)
28/07/2014	13h00	PR Newswire (US)	Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo...	AMEX:LRP	Lorus Therapeutics, (New)
15/07/2014	22h46	PR Newswire (US)	Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014	AMEX:LRP	Lorus Therapeutics, (New)
15/07/2014	22h28	PR Newswire (US)	Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing	AMEX:LRP	Lorus Therapeutics, (New)
10/07/2014	13h00	PR Newswire (US)	Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast	AMEX:LRP	Lorus Therapeutics, (New)
19/06/2014	13h00	PR Newswire (US)	Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference	AMEX:LRP	Lorus Therapeutics, (New)
16/06/2014	13h00	PR Newswire (Canada)	Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference	AMEX:LRP	Lorus Therapeutics, (New)
10/06/2014	13h30	PR Newswire (Canada)	Lorus Therapeutics Provides Update on Warrants	AMEX:LRP	Lorus Therapeutics, (New)
23/10/2008	22h09	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:LRP	Lorus Therapeutics, (New)
21/10/2008	14h53	Edgar (US Regulatory)	-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)	AMEX:LRP	Lorus Therapeutics, (New)
17/10/2008	14h43	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:LRP	Lorus Therapeutics, (New)
15/10/2008	14h00	Marketwired	Lorus Therapeutics Announces Receipt of Milestone Payment and Extension of Exclusive License Agreement for Virulizin(R)	AMEX:LRP	Lorus Therapeutics, (New)
10/10/2008	23h02	Marketwired	Lorus Therapeutics Announces Voluntary Delisting From the NYSE Alternext	AMEX:LRP	Lorus Therapeutics, (New)
09/10/2008	14h15	Marketwired	Lorus Therapeutics Reports First Quarter Results for Fiscal Year 2009	AMEX:LRP	Lorus Therapeutics, (New)
03/10/2008	18h21	Edgar (US Regulatory)	Lorus Therapeutics Inc - Report of Foreign Issuer (6-K)	AMEX:LRP	Lorus Therapeutics, (New)
09/09/2008	14h15	Marketwired	Lorus Therapeutics Announces Publication on Drug Levels and Clearance Rates for Anticancer Drug LOR-2040	AMEX:LRP	Lorus Therapeutics, (New)
20/08/2008	14h00	Marketwired	Lorus Therapeutics Announces the Identification of a Potential Novel Biomarker in Patient Samples From a Clinical Trial of LOR-2	AMEX:LRP	Lorus Therapeutics, (New)
15/08/2008	14h27	Edgar (US Regulatory)	Lorus Therapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:LRP	Lorus Therapeutics, (New)
08/08/2008	23h16	Marketwired	Lorus Therapeutics Successfully Completes Rights Offering, Raising $3.71 Million	AMEX:LRP	Lorus Therapeutics, (New)
05/08/2008	14h00	Marketwired	Lorus Toxicology Program Supports Novel Route of Administration of the Anticancer Drug LOR-2040 in Bladder Cancer	AMEX:LRP	Lorus Therapeutics, (New)
29/07/2008	14h00	Marketwired	Lorus Therapeutics Announces Allowance of New United States Patent for its Anticancer Drug LOR-2040	AMEX:LRP	Lorus Therapeutics, (New)
21/07/2008	21h24	PR Newswire (US)	/C O R R E C T I O N from Source -- Lorus Therapeutics Inc./	NYSE:LRP